Indian stent makers gain on the back of price caps

 15-Sep-17, ET Healthworld 

Domestic stent makers are looking to capture a greater share of India’s coronary stent market on the back of an uptick in sales after the government slashed prices of the devices by over 80 per cent. While some multinational firms claim the move has made it unviable to supply their latest generation models, their local competitors claim to have come out as the winners.

Image: ET Healthworld

"In the last six months, we have seen a positive trend towards increased sales for domestic manufacturers. This is more so in Tier II & Tier III towns due to higher affordable access post reduction of prices," said Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD).

Domestic stent firms are aiming for 60 per cent of the market in 2017/18, estimated to be worth INR12 bn (USD183 mn) now.

 Read the full article 

 Insights